Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
9.33
+0.17 (1.86%)
Nov 28, 2025, 4:00 PM EST - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $163.04 million as of November 28, 2025. Its market cap has increased by 200.05% in one year.
Market Cap
163.04M
Enterprise Value
158.36M
1-Year Change
200.05%
Ranking
Category
Stock Price
$9.33
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $163.04M, a decrease of -47.78%. That is a compound annual growth rate of -22.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 160.07M | 191.24% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |